# Lubiprostone

NDC: 70771-1764
Generic name: Lubiprostone
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230323

FDA application: ANDA214131

## Active ingredients

- LUBIPROSTONE: 24 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1764"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1764
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=81f9c9de-f89d-4ab0-a8ca-18d3691e42f9